Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice

Zoltaszek,Robert; Kowalczyk,Piotr; Kowalczyk,Magdalena C.; Hanausek,Margaret; Kilianska,Zofia  M.; Slaga,Thomas  J.; Walaszek,Zbigniew

doi:10.3892/ol.2010.221

January-February 2011 Volume 2 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2011 Volume 2 Issue 1

Full Size Image

Article

Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice

Authors:
- Robert Zoltaszek
- Piotr Kowalczyk
- Magdalena C. Kowalczyk
- Margaret Hanausek
- Zofia M. Kilianska
- Thomas J. Slaga
- Zbigniew Walaszek
View Affiliations / Copyright

Affiliations: Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA, Department of Cytobiochemistry, University of Lodz, Lodz 90-237, Poland
Pages: 145-154
|
Published online on: November 23, 2010

https://doi.org/10.3892/ol.2010.221
Expand metrics +

Abstract

Previous studies showed that dietary calcium D-glucarate (CG) inhibited benzo[a]pyrene (B[a]P)-induced A/J mouse lung tumorigenesis, suppressing cell proliferation and chronic inflammation and inducing apoptosis during late post-initiation stages. The present study aimed to investigate changes in the homeostasis of cytokines in blood serum, as well as alterations in biomarkers of inflammation and apoptosis in lung tissue caused by dietary CG during early post-initiation stages of B[a]P-induced lung tumorigenesis. Two doses of 3 mg of B[a]P were given intragastrically to A/J mice 2 weeks apart. CG administration in the AIN-93G diet (2 and 4%, w/w) commenced at 2 weeks following the second dose of B[a]P. The levels of interleukin (IL)-6, IL-10 and tumor necrosis factor α (TNFα) in blood serum were investigated by FCAP array analysis. Two weeks after the second dose of B[a]P, approximately 8- and 28-fold increases of TNFα and IL-6, respectively, occurred in the blood serum and an approximately 16% decrease of IL-10 levels compared to the untreated control group was noted. At 4 weeks after the second dose of B[a]P and after 2 weeks of CG administration in the diet, the 2 and 4% CG diets significantly reduced the levels of IL-6 and TNFα (by 70 and 33%, respectively). In a dose-related manner, the diets also increased the level of anti-inflammatory cytokine IL-10 compared to the B[a]P group. At 6 weeks after the second dose of B[a]P, the cytokine levels in the serum continued to show a decrease in the CG-treated groups. These events are accompanied by an increased level of cleaved caspase-9 product with a molecular weight of 37 kDa. In conclusion, dietary D-glucarate decreases the level of proinflammatory cytokines, increases the level of the anti-inflammatory cytokine IL-10 during early post-initiation stages of B[a]P-induced lung tumorigenesis in A/J mice and affects apoptotic induction.

View Figures

View References

1	Ferlay J, Autire P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007. View Article : Google Scholar : PubMed/NCBI
2	United States Cancer Statistics. Top Ten Cancer. 2006
3	Landi MT, Consonni D, Rotunno M, et al: Environment and Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health. 8:203–213. 2008. View Article : Google Scholar : PubMed/NCBI
4	Miura K, Bowman ED, Simon R, et al: Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res. 62:3244–3250. 2002.
5	Devesa SS, Bray F, Vizcaino AP and Parkin DM: International lung cancer trends by histologic type: male:female differences diminishing and adeno-carcinoma rates rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
6	Mountain CF: Revisions in the international system for staging lung cancer. Chest. 111:1710–1717. 1997. View Article : Google Scholar : PubMed/NCBI
7	Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:49–54. 2003. View Article : Google Scholar : PubMed/NCBI
8	Garber ME, Troyanskaya OG, Schluens K, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789. 2001. View Article : Google Scholar : PubMed/NCBI
9	Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adeno-carcinoma subclasses. Proc Natl Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI
10	Beer DG, Kardia SL, Huang CC, et al: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8:816–824. 2002.PubMed/NCBI
11	Endoh H, Tomida S, Yatabe Y, et al: Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol. 22:811–819. 2004. View Article : Google Scholar
12	Xi L, Lyons-Weiler J, Coello MC, et al: Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res. 11:4128–4135. 2005. View Article : Google Scholar : PubMed/NCBI
13	Meyerson M and Carbone D: Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol. 23:3219–3226. 2005. View Article : Google Scholar : PubMed/NCBI
14	He P, Varticovski L, Bowman ED, et al: Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuro-endocrine tumors by cDNA microarray. Hum Pathol. 35:1169–1209. 2004.PubMed/NCBI
15	Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
16	Potti A, Mukherjee S, Petersen R, et al: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. New England J Med. 355:570–580. 2006. View Article : Google Scholar
17	Reddy SP: The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med. 8:376–383. 2008. View Article : Google Scholar : PubMed/NCBI
18	Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S and Dubinett SM: Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 5:811–815. 2008. View Article : Google Scholar : PubMed/NCBI
19	Giri SN and Hollinger MA: Effect of cadmium on lung lysosomal enzymes in vitro. Arch Toxicol. 69:341–345. 1995. View Article : Google Scholar : PubMed/NCBI
20	Shimoi K, Saka N, Nozawa R, et al: Deglucuronidation of a flavonoid, luteolin monglucuronide, during inflammation. Drug Metab Disp. 29:1521–1524. 2001.PubMed/NCBI
21	Marshall T, Shult P and Busse WW: Release of lysosomal enzyme β-glucuronidase from isolated human eosinophils. J Allergy Clin Immunol. 82:550–555. 1988.
22	Cobben NA, Drent M, De Vries J, Wouters EF, van Dieijen-Visser MP and Henderson RF: Serum β-glucuronidase activity in a population of ex-coalminers. Clin Biochem. 32:659–664. 1999.
23	DiMatteo M, Antonini JM, van Dyke K and Reasor MJ: Characteristics of the acute phase pulmonary response to silica in rats. J Toxicol Environ Health. 47:93–108. 1996. View Article : Google Scholar : PubMed/NCBI
24	DiMatteo M and Reasor MJ: Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol Appl Pharmacol. 142:411–421. 1997. View Article : Google Scholar : PubMed/NCBI
25	Hirano S, Shimada T, Osugi J, Kodama N and Suzuki KT: Pulmonary clearance and inflammatory potence intratracheally instilled or acutely inhaled nickel sulfate in rats. Arch Toxicol. 68:548–554. 1994. View Article : Google Scholar : PubMed/NCBI
26	Matulionis D and Traurig HH: In situ response of lung macrophages and hydrolase activities to cigarette smoke. Lab Invest. 37:314–326. 1977.PubMed/NCBI
27	Pappas P, Sotiropoulou M, Karamanakos P, et al: Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1. Chem Bil Interac. 144:55–62. 2003.
28	Kong LY, Luster MI, Dixon D, O'Grady J and Rosenthal GJ: Inhibition of lung immunity after tracheal instillation of benzo[a]pyrene. Am J Resp Cit Care Med. 150:1123–1129. 1994.PubMed/NCBI
29	Levy G and Conchi J: β-Glucuronidase and the hydrolysis of glucuronides. Glucuronic Acid: Free and Combined. Academic Press; New York: pp. 301–364. 1966
30	Marsh CA: Metabolism of D-glucarolactone in mammalian systems. Identification of D-glucaric acid as a normal constituent of urine. Biochem J. 86:77–86. 1963.PubMed/NCBI
31	Matsui M, Fukuo A, Watanabe Y, Wanibe T and Okada M: Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. IV. Fluorometric method for the determination of D-glucaric acid in serum. Chem Phar Bull. 20:845–848. 1972. View Article : Google Scholar : PubMed/NCBI
32	Blumenthal HJ, Lucuta VL and Blumenthal DC: Specific enzymic assay for D-glucarate in human serum. Anal Biochem. 185:286–293. 1990. View Article : Google Scholar : PubMed/NCBI
33	Colombi A, Maroni M, Antonini C, Fait A, Zocchetti C and Foa V: Influence of sex, age and smoking habits on the urinary excretion of D-glucaric acid. Clin Chim Acta. 128:349–358. 1983. View Article : Google Scholar : PubMed/NCBI
34	Mocarelli P, Brambilla P, Colombo L, et al: A new method for D-glucaric acid excretion measurement that is suitable for automated instruments. Clin Chem. 34:2238–2290. 1988.PubMed/NCBI
35	Batt HM and Siest G: Laboratory tests as indirect indications of the activity of drug metabolizing enzymes use of glucaric acid and gamma-glutamyl-transpeptidase. Dev Clin Biochem. 2:178–192. 1980.
36	Yokoyama M, Matsuoka S and Wakui A: Activation of tegafur and urinary excretion of D-glucaric acid in tumor-bearing hosts. In: Recent Adv Chemother, Proc Int Congr Chemother 14th. Univ Tokyo Press; Tokyo: pp. 113–115. 1985
37	Dohrmann RE: β-Glucuronidase. Springer-Verlag; Berlin: 1969
38	Masaki H: Metabolic pathway of dermal D-glucaric acid synthesis from D-glucuronolactone. D-Glucaric acid and D-glucuronolactone dehydrogenase in human skin. β-Gucuronidase feedback mechanism. Nippon Hifuka Gakkai Zashi. 82:151–158 Chem Abstr. 78:2709b–27062u. 1972.
39	Dutton GJ: Glucuronidation of Drugs and Other Compounds. CRC Press; Boca Raton, FL: 1980
40	Clark AG, Fischer FJ, Milburn P, Smith RL and Williams RL: The role of gut flora in the enterohepatic circulation of stilboestrol in the rat. Biochem J. 112:17–18. 1988.PubMed/NCBI
41	Walaszek Z: Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett. 54:1–8. 1990. View Article : Google Scholar : PubMed/NCBI
42	Walaszek Z: Chemopreventive properties of D-glucaric acid derivatives. Cancer Bull. 45:453–457. 1993.
43	Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J and Slaga TJ: Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. Int J Oncol. 16:43–48. 2000.PubMed/NCBI
44	Walaszek Z, Szemraj J, Hanausek M, Adams AK and Sherman U: D-Glucaric acid content of various fruits and vegetables and cholesterol lowering effects of dietary D-glucarate in the rat. Nutr Res. 16:673–682. 1996. View Article : Google Scholar
45	Zoltaszek R, Hanausek M, Kiliańska ZM and Walaszek Z: The biological role of D-glucaric acid and its derivatives potential use in medicine. Adv Hyg Exptl Med. 62:451–462. 2008.PubMed/NCBI
46	Kishimoto T: Interleukin-6: from basic science to medicine – 40 years in immunology. Annu Rev Immunol. 23:1–21. 2005.
47	Wajant H, Pfizenmaier K and Scheurich P: Tumor necrosis factor signaling. Cell Death Differ. 10:45–65. 2003. View Article : Google Scholar : PubMed/NCBI
48	Coussens LM and Werb Z: Inflammatory cells and cancer: think different! J Exp Med. 193:F23–F26. 2001.
49	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2001. View Article : Google Scholar
50	Zoltaszek R, Hanausek M, Slaga TJ and Walaszek Z: Proapoptotic effects of D-glucarate on chemically induced lung tumorigenesis in A/J mice. Proc Am Assoc Cancer Res. 48:7952007.
51	Zoltaszek R, Grzelak M, Hanausek M, Kilianska Z, Slaga TJ and Walaszek Z: Effects of dietary D-glucarate on biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene (B[a]P)-induced lung tumorigenesis in A/J mice. Proc Am Assoc Cancer Res. 49:5322008.PubMed/NCBI
52	Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J and Iruela-Arispe M: Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. PNAS USA. 98:12485–12490. 2001. View Article : Google Scholar
53	De Marzo AM, Marchi VL, Epstein JI and Nelson WG: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 155:1985–1992. 1999.PubMed/NCBI
54	Kuper H, Adami HO and Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med. 248:171–173. 2000. View Article : Google Scholar : PubMed/NCBI
55	Baron JA and Sandler RS: Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med. 51:511–523. 2000. View Article : Google Scholar : PubMed/NCBI
56	Williams CS, Mann M and DuBois RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 18:7908–7916. 1999. View Article : Google Scholar : PubMed/NCBI
57	Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A and Musiani P: The intriguing role of polymorphonuclear neutrophils in anti-tumor reactions. Blood. 97:339–345. 2001.
58	Wahl LM and Kleinman HK: Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst. 90:1583–1584. 1998. View Article : Google Scholar : PubMed/NCBI
59	Coussens LM, Raymond WW, Bergers G, et al: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13:1382–1397. 1999. View Article : Google Scholar : PubMed/NCBI
60	Rothenberg ME: Eosinophilia. N Eng J Med. 338:1592–1600. 1998. View Article : Google Scholar : PubMed/NCBI
61	Gouon-Evans V, Rothenberg ME and Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development. 127:2269–2282. 2000.PubMed/NCBI
62	Lin EY, Nguyen AV, Russel RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
63	Ono M, Torisu H, Fukushi J, Nishie A and Kuwano M: Biological implications of macrophage infiltration in human angiogenesis. Cancer Chemother Pharmacol. 43:S69–S71. 1999. View Article : Google Scholar : PubMed/NCBI
64	Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S and Kuwano M: Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer. 85:182–188. 2000. View Article : Google Scholar
65	Coussens LM, Tinkel CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
66	Walaszek Z, Hanausek-Walaszek M and Webb TE: Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. Cancer Lett. 33:25–32. 1986. View Article : Google Scholar : PubMed/NCBI
67	Gysin R, Azzi A and Visarius T: Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 16:1952–1954. 2002.PubMed/NCBI
68	Boivin D, Blanchette M, Barrette S, Moghrabi A and Béliveau R: Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res. 27:937–948. 2007.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Related Articles